Amylin Pharmaceuticals Recent News
Morgan Stanley Says Risks Remain On Amylin
Citi Comments on Amylin Pharmaceuticals Drugs Results
Deutsche Bank To Hold 36th Annual Healthcare Conference Next Week
Jefferies Comments On ALMN QTc Analysis
Hapoalim Securities Downgrades AMLN To Hold From Buy
Piper Jaffray Upgrades AMLN To Neutral; Raises PT To $20
Jefferies Sees Upside To Amylin YE2011 Guidance